Eravacycline: a comprehensive review of in vitro activity, clinical efficacy, and real-world applications
Introduction The escalating threat of multidrug-resistant organisms necessitates constant
exploration for novel antimicrobial agents. Eravacycline has emerged as a promising …
exploration for novel antimicrobial agents. Eravacycline has emerged as a promising …
In Vitro Antimicrobial Activity of Five Newly Approved Antibiotics against Carbapenemase-Producing Enterobacteria—A Pilot Study in Bulgaria
R Markovska, P Stankova, T Stoeva, E Keuleyan… - Antibiotics, 2024 - mdpi.com
To solve the problem with pan-drug resistant and extensively drug-resistant Gram-negative
microbes, newly approved drugs such as ceftazidime/avibactam, cefiderocol, plazomicin …
microbes, newly approved drugs such as ceftazidime/avibactam, cefiderocol, plazomicin …
Dynamic evolution of ceftazidime-avibactam resistance from a single patient through the IncX3_NDM-5 plasmid transfer and blaKPC mutation
C Tang, S Shen, W Yang, Q Shi, L Ding, R Han… - International Journal of …, 2024 - Elsevier
The rapid dissemination of carbapenem-resistant Enterobacterales (CRE) especially
carbapenem-resistant K. pneumoniae (CRKP) poses a great threat to global public health …
carbapenem-resistant K. pneumoniae (CRKP) poses a great threat to global public health …